A significantly higher transferrin saturation was observed in 50 men with lung cancer compared to 3113 cancer-free controls (33.9% vs. 30.07%, p<0.05) from the NHANES I cohort of over 14,000 individuals from USA [8]. This evidence concerns the gene TF and cancer.